Anderson Kenneth Carl 4
4 · C4 Therapeutics, Inc. · Filed Jun 4, 2026
Research Summary
AI-generated summary of this filing
C4 Therapeutics Director Kenneth Anderson Exercises Options
What Happened
Kenneth C. Anderson, a director of C4 Therapeutics (CCCC), exercised stock options on June 1, 2026. He exercised options to acquire 1,070 shares at an exercise price of $2.11 per share, for a total cash outlay of $2,258. The filing indicates no shares were sold in connection with the exercise.
Key Details
- Transaction date: 2026-06-01; Form 4 filed: 2026-06-04. (Filed within the normal reporting window.)
- Action: Option exercise (transaction code M). 1,070 shares acquired at $2.11 each; total cost $2,258.
- A derivative entry at $0 reflects the option converting into stock (no cash sale of shares).
- Footnotes: F1 confirms exercise for cash and no shares sold; F7 notes the underlying options were fully vested and exercisable. F2–F6 note certain shares are held in revocable/irrevocable trusts in which the reporting person disclaims beneficial ownership except for pecuniary interest.
- Shares owned after the transaction: not specified in this filing.
Context
This was a straightforward option exercise (paying cash to convert options into shares), not a cashless or immediate sale. Such exercises are common for insiders realizing vested equity and do not by themselves indicate a buy or sell signal about the company's prospects.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-01$2.11/sh+1,070$2,258→ 69,300 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F7]2026-06-01−1,070→ 0 totalExercise: $2.11Exp: 2026-07-12→ Common Stock (1,070 underlying)
- 129,877(indirect: By Trust)
Common Stock
[F2] - 74,581(indirect: By Trust)
Common Stock
[F3] - 74,581(indirect: By Trust)
Common Stock
[F4] - 3,623(indirect: By Trust)
Common Stock
[F5] - 3,623(indirect: By Trust)
Common Stock
[F6]
Footnotes (7)
- [F1]The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise.
- [F2]Shares held by the Kenneth C. Anderson 2021 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F5]Shares held by the Kenneth C. Anderson Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F6]Shares held by the Cynthia E. Anderson Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F7]The shares underlying this option are fully vested and exercisable.